Onco Actu du 14 septembre 2015

	3.1 Tabac
Are we all shills for Big Tobacco? [The Conversation] The sub-text of the Fin Review piece was plain: Sydney University was being hypocritical, publicly divesting in stocks that swelled its carbon footprint, while investing $2m in big tobacco.
Researchers call for retraction of NEJM paper showing dangers of e-cigarettes [Retraction Watch] Critics, however, have claimed that to obtain such high levels of formaldehyde, the NEJM authors superheated the vapor from the e-cigs to levels that would create a well-known, acrid puff called a “dry puff.” This sensation, they say, is so terrible that no self-respecting “vaper” would consider repeating it.
	3.5 Prévention - UV
Hispanics May Think They Can't Get Skin Cancer, But They're Wrong [NPR] Hispanic Americans are more likely than other Americans to be diagnosed with skin cancer in its later stages, when it's more apt to be fatal. One reason is the misconception that people with darker skin are immune from skin cancer, researchers say. Another is that public health campaigns tend to focus on lighter-skinned people, inadvertently reinforcing that belief.
	4. Dépistage, diagnostic et pronostic
How are cancer patients diagnosed? And could it be better? [Cancer Research UK] Next week, then NCIN will publish an updated report. In preparation for the new data, we thought we’d take an in-depth look at the different ways (or ‘routes’) patients are diagnosed, particularly at what we mean by an ‘emergency’ – and at how understanding and collecting this information can help improve cancer care.
	4.1 Dép., diag. & prono. - Prostate
Prostate cancer test which detects tumour size could save thousands of lives [The Telegraph] A £10 urine test for prostate cancer, which not only picks up the disease but also reveals the size of tumours so that doctors know whether to operate, could be available within 18 months.
	4.12 Biopsies liquides
Is It Appropriate To Offer The Public "Liquid Biopsies" For the Early Detection Of Cancer? [Dr Len] It will be interesting to see how the regulatory agencies and the insurers approach this brave new world. However, in the meantime I suspect there are a number of knowledgeable experts who consider this a step too far and would agree with me that this test is simply not ready for prime time.
	4.9 Dép., diag. & prono. - Sein
Multiple Oncotype DX® Outcomes Studies, Including Results from NCI-sponsored TAILORx Breast Cancer Trial, to be Presented at 2015 European Cancer Congress [Genomic Health] First Read-out from Watershed TAILORx, Largest-Ever Adjuvant Breast Cancer Trial, Accepted as Oral Presentation with "Best Abstract" Designation at the 2015 European Cancer Congress Presidential Session.
	5. Traitements
A Better Class of Cancer Drugs [San Diego State University] An SDSU chemist has developed a technique to identifying potential cancer drugs that are less likely to produce side effects.
Cancer patient's ribs replaced with 3-D printed titanium set [UPI] Surgeons in Spain implanted a set of 3-D printed, titanium ribs into a man with a chest wall sarcoma to replace his own ribs that had to be removed.
	5.4 Traitements - Economie
Pharma Plays The “Value” Card: Drug Spending Then And Now [Xconomy] With the majority of Americans favoring government interventions to lower the price of drugs, its pretty clear that the “value proposition” has been a losing strategy for industry. Pharma’s promises that it is providing drugs of great “value” to consumers will continue to ring hollow if it can’t produce clear and convincing data to support its claims.
	5.6 ESMO
Bayer to Present Data from Oncology Portfolio at ECC2015 in Vienna [Bayer] Additional analyses of regorafenib from the Phase III CONCUR and Phase IIIb CONSIGN clinical trials in metastatic colorectal cancer Clinical data presentation of Bayer’s CDK inhibitor roniciclib (BAY-1000394) in patients with extensive disease small cell lung cancer Additional results from Phase III ALSYMPCA trial and U.S. expanded access program of radium-223 dichloride in metastatic castration-resistant prostate cancer
Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015 [Pfizer] Data from six abstracts, including new data in mesothelioma, urothelial, (e.g. bladder) and gastric/gastroesophageal cancers, to be presented at the European Cancer Congress (ECC).
	6.10 Politiques
Great news as Government signals backing for cancer plan [Cancer Research UK] These commitments are going to make big improvements for patients, and this is great news.
Target of four-week cancer diagnosis [BBC News] More details of plans to improve cancer care in England have been revealed.
Cancer patients to get faster diagnosis, says Jeremy Hunt [The Guardian] The “more patient-centred” plans will mean that from 2020 patients will be given a definitive cancer diagnosis leading to treatment – or the all-clear – within 28 days of being referred by a GP.
	6.6 Publications
Reflections on a Twitter Discussion About ORCID [UK Web Focus] I hope the Twitter discussion on the original blog post has helped clarify the main purpose of ORCID and identified a practice for using ORCID which can co-exist with use of researcher profiling tools.
	6.8 Communication
Answers [Portland Roots Media] The most mind-blowing thing about connecting with Mike Fountain and finding this match is that it only took about twelve hours. We created Tess's page on the morning of Wednesday, August 12th, set it loose on Facebook and Twitter, and literally that same evening, the night of the 12th, Mike had found it and emailed us.